Literature DB >> 18378443

Lineage-specific silencing of human IL-10 gene expression by promoter methylation in cervical cancer cells.

Anita Szalmás1, Ferenc Bánáti, Anita Koroknai, Brigitta László, Eniko Fehér, Dániel Salamon, Lajos Gergely, János Minárovits, József Kónya.   

Abstract

Epigenetic analysis was performed to demonstrate that the normal and neoplastic epithelial cells do not serve as the source of the locally elevated IL-10 production during cervical carcinogenesis. Bisulfite sequencing was used to correlate promoter CpG methylation with the transcription of the gene. Lack of IL-10 transcription in HeLa, SiHa, Caski, HT-3, C33-A, HaCaT cell lines and in primary human keratinocytes correlated consistently with the methylated state of the proximal CpG residues, particularly with the two most proximal CpGs at positions -185 and -110. These two sites were also highly methylated in normal and malignant cervical cells directly isolated from patient material. On the other hand, IL-10 producing peripheral blood mononuclear cells had unmethylated CpG residues in the proximal promoter associated with acetylated H3 and H4 histones as determined by chromatin immunoprecipitation. In HeLa carrying epigenetically silenced endogeneous IL-10 promoter, the transfected non-CpG methylated 1 kb and 0.6 kb proximal promoter fragments could drive reporter gene expression, which was reversed by cassette methylation of these promoter fragments. In conclusion, the CpG methylation pattern of the proximal promoter is implicated as a major determinant of transcriptional silencing of human IL-10 expression in cells of cervical epithelial origin.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18378443     DOI: 10.1016/j.ejca.2008.02.046

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  7 in total

1.  Prostaglandin E2 Reverses the Effects of DNA Methyltransferase Inhibitor and TGFB1 on the Conversion of Naive T Cells to iTregs.

Authors:  Mehmet Sahin; Emel Sahin
Journal:  Transfus Med Hemother       Date:  2019-09-19       Impact factor: 3.747

Review 2.  Highlights in pathogenesis of vitiligo.

Authors:  Ghada F Mohammed; Amal Ha Gomaa; Mohammed Saleh Al-Dhubaibi
Journal:  World J Clin Cases       Date:  2015-03-16       Impact factor: 1.337

Review 3.  Cell type-specific regulation of IL-10 expression in inflammation and disease.

Authors:  Christian M Hedrich; Jay H Bream
Journal:  Immunol Res       Date:  2010-07       Impact factor: 2.829

Review 4.  Epigenetic control of cytokine gene expression: regulation of the TNF/LT locus and T helper cell differentiation.

Authors:  James V Falvo; Luke D Jasenosky; Laurens Kruidenier; Anne E Goldfeld
Journal:  Adv Immunol       Date:  2013       Impact factor: 3.543

5.  5-azacytidine promotes an inhibitory T-cell phenotype and impairs immune mediated antileukemic activity.

Authors:  Thomas Stübig; Anita Badbaran; Tim Luetkens; York Hildebrandt; Djordje Atanackovic; Thomas M C Binder; Boris Fehse; Nicolaus Kröger
Journal:  Mediators Inflamm       Date:  2014-03-13       Impact factor: 4.711

6.  IL10 hypomethylation is associated with the risk of gastric cancer.

Authors:  Junjian Tang; Ranran Pan; Lele Xu; Qinghua Ma; Xiuru Ying; Jun Zhao; Haibin Zhao; Li Miao; Yue Xu; Shiwei Duan; Jinzhi Wang
Journal:  Oncol Lett       Date:  2021-01-31       Impact factor: 2.967

7.  IL-10 promoter hypomethylation is associated with increased IL-10 expression and poor survival in hepatocellular carcinoma.

Authors:  Xianjing Zhang; Mingzhu Lu; Yun Xu; Guangzhao He; Qian Liu; Jing Zhu; Changsong Zhang; Xiaoli Zhang
Journal:  Transl Cancer Res       Date:  2019-08       Impact factor: 1.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.